Genetics of menopause-associated diseases

Area of Science:

• Genetics
• Postmenopausal Health
• Chronic Disease Susceptibility

Background:

• Menopause affects millions globally, leading to hormonal changes.
• Postmenopausal women face increased risks of chronic conditions like cardiovascular disease, osteoporosis, and Alzheimer's dementia.
• These chronic disorders have both environmental and strong genetic components.

Purpose of the Study:

• To review current data on genetic variations contributing to susceptibility to four common postmenopausal chronic syndromes: osteoporosis (OP), osteoarthritis (OA), Alzheimer's disease (AD), and coronary artery disease (CAD).
• To explore how gene polymorphisms explain the inheritance and co-segregation of these disorders.
• To identify potential common genetic factors, particularly within the estrogen response cascade, underlying these conditions.

Main Methods:

• Review of existing clinical and genetic data.
• Analysis of candidate genes associated with OP (e.g., VDR gene), CAD (e.g., ACE gene), and other postmenopausal disorders.
• Investigation of gene polymorphisms, including those in the estrogen receptor (ERs) pathway.

Main Results:

• Genetic variations are implicated in the susceptibility to osteoporosis, osteoarthritis, Alzheimer's disease, and coronary artery disease.
• Specific genes like VDR and ACE are linked to skeletal and cardiovascular health, respectively.
• Estrogen response cascade genes are strong candidates for a shared genetic background influencing multiple postmenopausal disorders.

Conclusions:

• Genetic polymorphisms play a significant role in the development of common postmenopausal chronic diseases.
• Understanding these genetic factors can aid in identifying at-risk individuals.
• Pharmacogenetic approaches, guided by genetic profiles, may optimize treatment responsiveness in postmenopausal women.